Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra ™) in Subjects Aged 6 Months and Older in Vietnam

Condition:   Influenza Intervention:   Biological: Quadrivalent Influenza Vaccine Sponsor:   Sanofi Pasteur, a Sanofi Company Not yet recruiting

Source: ClinicalTrials.gov - December 5, 2018 Category: Research Source Type: clinical trials